Zdrowie i gospodarka · 01/06/2020
FDA Establishes Public Docket to Solicit Comments on Patent Information in the Orange Book
The FDA is seeking public input on the types of patents listed in the Orange Book and their impact on drug development, as part of a new docket established to gather comments on patent information listing practices.